|
1
|
Cross M, Smith E, Hoy D, Nolte S, Ackerman
I, Fransen M, Bridgett L, Williams S, Guillemin F, Hill CL, et al:
The global burden of hip and knee osteoarthritis: Estimates from
the global burden of disease 2010 study. Ann Rheum Dis.
73:1323–1330. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hunter DJ, Schofield D and Callander E:
The individual and socioeconomic impact of osteoarthritis. Nat Rev
Rheumatol. 10:437–441. 2014.PubMed/NCBI
|
|
3
|
Felson DT: Clinical practice.
Osteoarthritis of the knee. N Engl J Med. 354:841–848. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Goldring MB and Otero M: Inflammation in
osteoarthritis. Curr Opin Rheumatol. 23:471–478. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kapoor M, Martel-Pelletier J, Lajeunesse
D, Pelletier JP and Fahmi H: Role of proinflammatory cytokines in
the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 7:33–42.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Martel-Pelletier J: Pathophysiology of
osteoarthritis. Osteoarthritis Cartilage. 12 Suppl A:S31–S33. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Saklatvala J: Tumour necrosis factor alpha
stimulates resorption and inhibits synthesis of proteoglycan in
cartilage. Nature. 322:547–549. 1986. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Goldring MB, Fukuo K, Birkhead JR, Dudek E
and Sandell LJ: Transcriptional suppression by interleukin-1 and
interferon-gamma of type II collagen gene expression in human
chondrocytes. J Cell Biochem. 54:85–99. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Richardson DW and Dodge GR: Effects of
interleukin-1beta and tumor necrosis factor-alpha on expression of
matrix-related genes by cultured equine articular chondrocytes. Am
J Vet Res. 61:624–630. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cruz R, Miranda-Sánchez M, Solís-García DB
and Kouri J: Recent patents on metalloproteinases as biomarkers in
osteoarthritis diagnosis and treatment. Recent Patents on
Biomarkers. 4:1–10. 2014. View Article : Google Scholar
|
|
11
|
Müller RD, John T, Kohl B, Oberholzer A,
Gust T, Hostmann A, Hellmuth M, Laface D, Hutchins B, Laube G, et
al: IL-10 overexpression differentially affects cartilage matrix
gene expression in response to TNF-alpha in human articular
chondrocytes in vitro. Cytokine. 44:377–385. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jansen NW, Roosendaal G, Hooiveld MJ,
Bijlsma JW, van Roon JA, Theobald M and Lafeber FP: Interleukin-10
protects against blood-induced joint damage. Br J Haematol.
142:953–961. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Y and Lou S: Direct protective effect
of interleukin-10 on articular chondrocytes in vitro. Chin Med J
(Engl). 114:723–725. 2001.PubMed/NCBI
|
|
14
|
Fernandes JC, Martel-Pelletier J and
Pelletier JP: The role of cytokines in osteoarthritis
pathophysiology. Biorheology. 39:237–246. 2002.PubMed/NCBI
|
|
15
|
Borzi RM, Mazzetti I, Marcu KB and
Facchini A: Chemokines in cartilage degradation. Clin Orthop Relat
Res. 427:S53–S61. 2004. View Article : Google Scholar
|
|
16
|
Cho H, Lee S, Park SH, Huang J, Hasty KA
and Kim SJ: Synergistic effect of combined growth factors in
porcine intervertebral disc degeneration. Connect Tissue Res.
54:181–186. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cho H, Walker A, Williams J and Hasty KA:
Study of osteoarthritis treatment with anti-inflammatory drugs:
Cyclooxygenase-2 inhibitor and steroids. Biomed Res Int.
2015:5952732015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sokolove J and Lepus CM: Role of
inflammation in the pathogenesis of osteoarthritis: Latest findings
and interpretations. Ther Adv Musculoskelet Dis. 5:77–94. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guerne PA, Carson DA and Lotz M: IL-6
production by human articular chondrocytes. Modulation of its
synthesis by cytokines, growth factors, and hormones in vitro. J
Immunol. 144:499–505. 1990.PubMed/NCBI
|
|
20
|
Lotz M, Terkeltaub R and Villiger PM:
Cartilage and joint inflammation. Regulation of IL-8 expression by
human articular chondrocytes. J Immunol. 148:466–473.
1992.PubMed/NCBI
|
|
21
|
Mrosewski I, Jork N, Gorte K, Conrad C,
Wiegand E, Kohl B, Ertel W, John T, Oberholzer A, Kaps C and
Schulze-Tanzil G: Regulation of osteoarthritis-associated key
mediators by TNFα and IL-10: Effects of IL-10 overexpression in
human synovial fibroblasts and a synovial cell line. Cell Tissue
Res. 357:207–223. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kaneko S, Satoh T, Chiba J, Ju C, Inoue K
and Kagawa J: Interleukin-6 and interleukin-8 levels in serum and
synovial fluid of patients with osteoarthritis. Cytokines Cell Mol
Ther. 6:71–79. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Valcamonica E, Chighizola CB, Comi D, De
Lucia O, Pisoni L, Murgo A, Salvi V, Sozzani S and Meroni PL:
Levels of chemerin and interleukin 8 in the synovial fluid of
patients with inflammatory arthritides and osteoarthritis. Clin Exp
Rheumatol. 32:243–250. 2014.PubMed/NCBI
|
|
24
|
Rowan AD, Koshy PJ, Shingleton WD, Degnan
BA, Heath JK, Vernallis AB, Spaull JR, Life PF, Hudson K and
Cawston TE: Synergistic effects of glycoprotein 130 binding
cytokines in combination with interleukin-1 on cartilage collagen
breakdown. Arthritis Rheum. 44:1620–1632. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Poree B, Kypriotou M, Chadjichristos C,
Beauchef G, Renard E, Legendre F, Melin M, Gueret S, Hartmann DJ,
Malléin-Gerin F, et al: Interleukin-6 (IL-6) and/or soluble IL-6
receptor down-regulation of human type II collagen gene expression
in articular chondrocytes requires a decrease of Sp1.Sp3 ratio and
of the binding activity of both factors to the COL2A1 promoter. J
Biol Chem. 283:4850–4865. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Malemud CJ: Anticytokine therapy for
osteoarthritis: Evidence to date. Drugs Aging. 27:95–115. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Goldring MB: The role of cytokines as
inflammatory mediators in osteoarthritis: Lessons from animal
models. Connect Tissue Res. 40:1–11. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Matsukawa A, Yoshimura T, Maeda T,
Ohkawara S, Takagi K and Yoshinaga M: Neutrophil accumulation and
activation by homologous IL-8 in rabbits. IL-8 induces destruction
of cartilage and production of IL-1 and IL-1 receptor antagonist in
vivo. J Immunol. 154:5418–5425. 1995.PubMed/NCBI
|
|
29
|
Olson TS and Ley K: Chemokines and
chemokine receptors in leukocyte trafficking. Am J Physiol Regul
Integr Comp Physiol. 283:R7–R28. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Borzi RM, Mazzetti I, Magagnoli G,
Paoletti S, Uguccioni M, Gatti R, Orlandini G, Cattini L and
Facchini A: Growth-related oncogene alpha induction of apoptosis in
osteoarthritis chondrocytes. Arthritis Rheum. 46:3201–3211. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Olivotto E, Otero M, Marcu KB and Goldring
MB: Pathophysiology of osteoarthritis: Canonical
NF-κB/IKKβ-dependent and kinase-independent effects of IKKα in
cartilage degradation and chondrocyte differentiation. RMD Open. 1
Suppl 1:e0000612015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hayashi S, Nishiyama T, Hashimoto S,
Fujishiro T, Kanzaki N, Iwasa K, Sakata S, Chinzei N, Kuroda R and
Kurosaka M: P21 regulates MMP-13 expression through STAT3 signaling
in chondrocytes. Osteoarthritis and Cartilage. 21 Suppl:S46–S47.
2013. View Article : Google Scholar
|
|
33
|
Sultana F and Rasool M: A novel
therapeutic approach targeting rheumatoid arthritis by combined
administration of morin, a dietary flavanol and non-steroidal
anti-inflammatory drug indomethacin with reference to
pro-inflammatory cytokines, inflammatory enzymes, RANKL and
transcription factors. Chem Biol Interact. 230:58–70. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Latourte A, Cherifi C, Korng EH, Bouaziz
W, Brentano TF, Cohen-Solal M, Haÿ E and Richette P: Inhibition of
the interleukin-6-induced STAT3 signalling pathway is
chondroprotective. ECTS-IBMS. 2015.
|
